P2X receptors as a therapeutic opportunity – PRESTO
Acronym: PRESTO
Principal investigator: for IVN Carmen C. Diaconu, PhD
(2022-2026; EU- COST, COST CA21130) – Principal investigator: for IVN Carmen C. Diaconu, PhD
Our website uses cookies to improve and personalize your experience. Our website may also include cookies from third parties such as Google Analytics. By using the site, you agree to the Cookies Policy and the Privacy Policy.ACCEPTNO
